Vaishali Pharma Limited Asset Resilience Ratio
Vaishali Pharma Limited asset resilience ratio. Vaishali Pharma Limited (VAISHALI) has an Asset Resilience Ratio of 25.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VAISHALI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Vaishali Pharma Limited (2016–2025)
Asset resilience ratio of Vaishali Pharma Limited from 2016 to 2025. This chart shows how Vaishali Pharma Limited's Asset Resilience Ratio has changed over time. Read debt load of Vaishali Pharma Limited for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Vaishali Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VAISHALI total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs10.46 Million | 0.86% |
| Short-term Investments | Rs298.02 Million | 24.44% |
| Total Liquid Assets | Rs308.48 Million | 25.30% |
Asset Resilience Insights
- Very High Liquidity: Vaishali Pharma Limited maintains exceptional liquid asset reserves at 25.30% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Vaishali Pharma Limited Industry Peers by Asset Resilience Ratio
Compare Vaishali Pharma Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Vaishali Pharma Limited Asset Resilience Ratio by Year (2016–2025)
Vaishali Pharma Limited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Vaishali Pharma Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 27.42% | Rs301.23 Million ≈ $3.26 Million |
Rs1.10 Billion ≈ $11.88 Million |
+25.11pp |
| 2024-03-31 | 2.31% | Rs18.50 Million ≈ $200.09K |
Rs799.56 Million ≈ $8.65 Million |
-14.01pp |
| 2023-03-31 | 16.32% | Rs128.79 Million ≈ $1.39 Million |
Rs789.07 Million ≈ $8.53 Million |
+0.13pp |
| 2022-03-31 | 16.19% | Rs132.16 Million ≈ $1.43 Million |
Rs816.24 Million ≈ $8.83 Million |
+1.93pp |
| 2021-03-31 | 14.26% | Rs122.79 Million ≈ $1.33 Million |
Rs861.23 Million ≈ $9.31 Million |
+16.90pp |
| 2020-03-31 | -2.64% | Rs-17.50 Million ≈ $-189.22K |
Rs662.04 Million ≈ $7.16 Million |
+1.58pp |
| 2019-03-31 | -4.22% | Rs-29.00 Million ≈ $-313.66K |
Rs687.51 Million ≈ $7.44 Million |
-19.56pp |
| 2018-03-31 | 15.34% | Rs98.66 Million ≈ $1.07 Million |
Rs643.23 Million ≈ $6.96 Million |
+15.78pp |
| 2017-03-31 | -0.44% | Rs-1.98 Million ≈ $-21.40K |
Rs446.49 Million ≈ $4.83 Million |
-1.02pp |
| 2016-03-31 | 0.58% | Rs2.88 Million ≈ $31.16K |
Rs497.73 Million ≈ $5.38 Million |
-- |
About Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more